GTR 69588231
Bids Are Invited For Centralized Acquisition Of Antineoplastic And Cytostatic Drugs With The Aim Of Supplying Huf Federal University Hospitals That Are Part Of The Brazilian Company Of Hospital Services Ebserh Network.
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
69588231
Tendering Authority
Subscribe to view
Tender No
24/2023
Financer Name
Self-Funded
Work Title
Bids Are Invited For Centralized Acquisition Of Antineoplastic And Cytostatic Drugs With The Aim Of Supplying Huf Federal University Hospitals That Are Part Of The Brazilian Company Of Hospital Services Ebserh Network.
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
15-09-2023
Closed
Work Detail
Centralized Acquisition Of Antineoplastic And Cytostatic Drugs With The Aim Of Supplying Huf Federal University Hospitals That Are Part Of The Brazilian Company Of Hospital Services Ebserh Network.. Irinotecan Hydrochloride, Cytarabine, Pamidronate Sodium, Dacarbazine, Capecitabine, Epirubicin Hydrochloride, Gemcitabine Hydrochloride, Megestrol Acetate, Letrozole, Cisplatin, Imatinib Mesylate, Thioguanine, Cyclophosphamide, Carboplatin, Cyclophosphamide, Mitotane, Docetaxel, Flutamide, Methotrexate, Cisplatin Bina, Melphalan, Methotrexate, Sodium Pamidronate, Oxaliplatin, Vinblastine, Bicalutamide, Doxorubicin Hydrochloride, Chlorambucil, Paclitaxel, Etoposide, Dacarbazine, Exemestane, Topotecan Hydrochloride, Vinorelbine, Paclitaxel, Idarubicin Hydrochloride, Oxaliplatin, Methotrexate, Mitoxantrone Hydrochloride, Cisplatin Uracil, Zoledronic Acid, Carmustine, Vincristine, Docetaxel, Ifosfamide, Leuprorelin Acetate, Doxorubicin Hydrochloride, Cytarabine, Anastrozole, Cytarabine, Mercaptopurine, Docetaxel, Imatinib Mesylate, Vinorelbine, Ifosfamide, Rituximab, Doxorubicin Hydrochloride, Irinotecan Hydrochloride, Gefitinib, Tamoxifen Citrate, Bortezomib, Da Satinib, Daunorubicin, Tretinoin, Oxaliplatin, Melphalan, Paclitaxel, Carboplatin, Fluorouracil, Asparaginase, Cyclophosphamide, Idarubicin Hydrochloride, Vinorelbine, Goserelin Acetate, Doxorubicin Hydrochloride, Cladribine, Gemcitabine Hydrochloride, Fulvestrant, Bleomycin Sulfate, Rituximab, Hydroxyurea, Bevacizumab, Capecitabine Agrelida Hydrochloride, Fludarabine Phosphate, Trastuzumab ,Busulfan,Pegaspargase,Goserelin Acetate,Leuprorelin Acetate,Nilotinib,Dasatinib
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
0a840bab-cc16-4881-963d-294320e546c7.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.